Table I.
Association between serum GASL1 and clinicopathological characteristics of patients with gastric cancer.
GASL1 expression level | |||||
---|---|---|---|---|---|
Characteristics | No. of cases | High (n=44) | Low (n=44) | χ2 | P-value |
Age (years) | |||||
>45 | 48 | 22 | 26 | 0.73 | 0.39 |
<45 | 40 | 22 | 18 | ||
Gender | |||||
Male | 52 | 23 | 29 | 1.69 | 0.19 |
Female | 36 | 21 | 15 | ||
Drinking | |||||
Yes | 47 | 22 | 25 | 0.41 | 0.52 |
No | 41 | 22 | 19 | ||
Smoking | |||||
Yes | 42 | 19 | 23 | 0.73 | 0.39 |
No | 46 | 25 | 21 | ||
Tumor size (cm) | |||||
>5 | 45 | 17 | 28 | 5.50 | 0.02 |
<5 | 43 | 27 | 16 | ||
Tumor distant metastasis | |||||
Yes | 41 | 18 | 23 | 1.14 | 0.29 |
No | 47 | 26 | 21 |
GASL1, growth arrest associated lncRNA 1.